Related by context. Frequent words. (Click for all words.) 65 PF # [001] 65 MDV# 65 MGCD# [001] 64 Azixa 63 investigational compound 63 ISIS # 62 Perifosine 62 HspE7 62 PRX # 62 Phase IIa trial 62 kinase inhibitor 62 Phase Ib 61 ASA# 61 NGX# 61 RG# [001] 61 daclizumab 61 LymphoStat B 61 IMGN# 61 bapineuzumab 61 Phase 2b trial 60 APD# 60 XL# [003] 60 T DM1 60 vandetanib 60 FTY# 60 INCB# [002] 60 sunitinib 60 pralatrexate 60 CRx 60 Phase 2b clinical 60 phase IIb 59 CYT# 59 Clolar 59 Phase IIb trial 59 blinatumomab 59 Preclinical studies 59 Zerenex 59 mipomersen 59 Phase 2b study 59 denufosol 58 humanized monoclonal antibody 58 TREANDA 58 etanercept 58 anti angiogenic 58 PLX# 58 investigational drug 58 Genasense 58 maraviroc 58 Phase IIb 58 ofatumumab 58 dasatinib 58 Phase IIa clinical 58 efficacy endpoints 58 AP# [003] 58 potent inhibitor 58 vilazodone 58 pharmacodynamic 58 Kuvan 58 Phase 1b 58 RDEA# 58 FOLOTYN 58 Locteron 58 MGCD# [002] 57 Phase IIb clinical 57 temozolomide 57 ALN RSV# 57 Marqibo 57 TroVax 57 laquinimod 57 milnacipran 57 Phase 2a 57 antitumor activity 57 Phase 2a clinical 57 CTCE 57 PEG INTRON 57 kinase inhibitors 57 LUNESTA 57 RAD# [003] 57 preclinical 57 receptor antagonist 57 alemtuzumab 57 budesonide 57 tamibarotene 57 ALKS 57 Xcytrin 57 Atiprimod 57 Satraplatin 57 asenapine 57 cetuximab 57 Trexima 57 disease modifying 57 CBLB# 57 voreloxin 57 Telaprevir 57 perifosine 57 Phase III clinical trials 57 investigational oral 57 preclinical studies 56 linaclotide 56 eculizumab 56 tolerability